MRI-detectable pH nanosensors incorporated into hydrogels for in vivo sensing of transplanted-cell viability

Nature Materials

Volumn 12, Issue 3, 2013, Pages 268-275

  Chan, Kannie W Y ^a   Liu, Guanshu ^a,b   Song, Xiaolei ^a   Kim, Heechul ^a   Yu, Tao ^a   Arifin, Dian R ^a   Gilad, Assaf A ^a   Hanes, Justin ^a,c   Walczak, Piotr ^a   Van Zijl, Peter C M ^a,b   Bulte, Jeff W M ^a,b   McMahon, Michael T ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANATOMICAL IMAGES; BIOLUMINESCENCE IMAGING; CELL TRANSPLANTS; CELL-BASED THERAPY; HIGH RESOLUTION; IMMUNE REJECTION; MAGNETIC RESONANCE IMAGING (MRI); POTENTIAL BENEFITS;

CELL DEATH; HYDROGELS; MAGNETIC RESONANCE IMAGING;

NANOSENSORS;

BIOMATERIAL; CONTRAST MEDIUM; NANOMATERIAL;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL SURVIVAL; CELL TRANSPLANTATION; CHEMISTRY; EVALUATION; HYDROGEL; LIVER CELL; METHODOLOGY; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PH; TRANSPLANTATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL SURVIVAL; CELL TRANSPLANTATION; CONTRAST MEDIA; HEPATOCYTES; HYDROGELS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED BALB C; NANOSTRUCTURES;

MLCS; MLOWN;

EID: 84875461186     PISSN: 14761122     EISSN: 14764660     Source Type: Journal    
DOI: 10.1038/nmat3525     Document Type: Article

References (50)

1. Murua, A. et al. Cell microencapsulation technology: Towards clinical application. J. Control. Release 132, 76-83 (2008).
2. Orive, G. et al. Cell encapsulation: Promise and progress. Nature Med. 9, 104-107 (2003).
3. Lanza, R. P., Hayes, J. L. & Chick, W. L. Encapsulated cell technology. Nature Biotechnol. 14, 1107-1111 (1996).
4. Chang, T. M. Therapeutic applications of polymeric artificial cells. Nature Rev. 4, 221-235 (2005).
5. Elliott, R. B. et al. Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation. Xenotransplantation 14, 157-161 (2007).
6. Soon-Shiong, P. et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343, 950-951 (1994).
7. Lohr, M. et al. Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. Lancet 357, 1591-1592 (2001).
8. Bloch, J. et al. Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: Results of a phase I study. Hum. Gene Ther. 15, 968-975 (2004).
9. Fisher, B. et al. Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. J. Clin. Oncol. 7, 250-261 (1989).
10. Bulte, J. W. In vivo MRI cell tracking: Clinical studies. Am. J. Roentgenol. 193, 314-325 (2009).
11. Contag, P. R., Olomu, I. N., Stevenson, D. K. & Contag, C. H. Bioluminescent indicators in living mammals. Nature Med. 4, 245-247 (1998).
12. Yaghoubi, S. S. et al. Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma. Nature Clinic. Practice. Oncology 6, 53-58 (2009).
13. Hughes, R. D., Mitry, R. R. & Dhawan, A. Current status of hepatocyte transplantation. Transplantation 93, 342-347 (2012).
14. Mai, G. et al. Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes. Transplant. Proc. 37, 527-529 (2005).
15. Barnett, B. P. et al. Radiopaque alginate microcapsules for X-ray visualization and immunoprotection of cellular therapeutics. Mol. Pharm. 3, 531-538 (2006).
16. Barnett, B. P. et al. Fluorocapsules for improved function, immunoprotection, and visualization of cellular therapeutics with MR, US, and CT imaging. Radiology 258, 182-191 (2011).
17. Arifin, D. R. et al. Trimodal gadolinium-gold microcapsules containing pancreatic islet cells restore normoglycemia in diabetic mice and can be tracked by using US, CT, and positive-contrast MR imaging. Radiology 260, 790-798 (2011).
18. Kim, J. et al. Multifunctional capsule-in-capsules for immunoprotection and trimodal imaging. Angew. Chem. Int. Ed. 50, 2317-2321 (2011).
19. Barnett, B. P. et al. Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nature Med. 13, 986-991 (2007).
20. Ward, K. M., Aletras, A. H. & Balaban, R. S. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J. Magn. Reson. 143, 79-87 (2000).
21. Van Zijl, P. C. & Yadav, N. N. Chemical exchange saturation transfer (CEST): What is in a name and what isn't? Magn. Reson. Med. 65, 927-948 (2011).
22. Sherry, A. D. & Woods, M. Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. Annu. Rev. Biomed. Eng. 10, 391-411 (2008).
23. Terreno, E., Castelli, D. D. & Aime, S. Encoding the frequency dependence in MRI contrast media: The emerging class of CEST agents. Contrast Media Mol. imaging 5, 78-98 (2010).
24. Zhou, J., Payen, J. F., Wilson, D. A., Traystman, R. J. & van Zijl, P. C. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nature Med. 9, 1085-1090 (2003).
25. Coakley, R. J., Taggart, C., McElvaney, N. G. & O'Neill, S. J. Cytosolic pH and the inflammatory microenvironment modulate cell death in human neutrophils after phagocytosis. Blood 100, 3383-3391 (2002).
26. De Leon-Rodriguez, L. M. et al. Responsive MRI agents for sensing metabolism in vivo. Acc. Chem. Res. 42, 948-957 (2009).
27. Shrode, L. D., Tapper, H. & Grinstein, S. Role of intracellular pH in proliferation, transformation, and apoptosis. J. Bioenerg. Biomembr. 29, 393-399 (1997).
28. McMahon, M. T. et al. New 'multicolor' polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI. Magn. Reson. Med. 60, 803-812 (2008).
29. Liu, G. et al. In vivo multicolor molecular MR imaging using diamagnetic chemical exchange saturation transfer liposomes. Magn. Reson. Med. 67, 1106-1113 (2012).
30. Lim, F. & Sun, A. M. Microencapsulated islets as bioartificial endocrine pancreas. Science 210, 908-910 (1980).
31. Barnett, B. P. et al. Synthesis of magnetic resonance-, X-ray- and ultrasound-visible alginate microcapsules for immunoisolation and noninvasive imaging of cellular therapeutics. Nature Protocols 6, 1142-1151 (2011).
32. Tuch, B. E. et al. Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diab. Care 32, 1887-1889 (2009).
33. Takagi, I., Shimizu, H. & Yotsuyanagi, T. Application of alginate gel as a vehicle for liposomes. I. Factors affecting the loading of drug-containing liposomes and drug release. Chem. Pharm. Bull. (Tokyo) 44, 1941-1947 (1996).
34. Gardner, C. M., Burke, N. A. & Stover, H. D. Cross-linked microcapsules formed from self-deactivating reactive polyelectrolytes. Langmuir 26, 4916-4924 (2010).
35. Darrabie, M. D., Kendall, W. F. Jr & Opara, E. C. Characteristics of poly-L-ornithine-coated alginate microcapsules. Biomaterials 26, 6846-6852 (2005).
36. Dupraz, P. et al. Lentivirus-mediated Bcl-2 expression in - TC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion. Gene Ther. 6, 1160-1169 (1999).
37. Dufrane, D. et al. The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats. Biomaterials 27, 3201-3208 (2006).
38. Medarova, Z., Evgenov, N. V., Dai, G., Bonner-Weir, S. & Moore, A. In vivo multimodal imaging of transplanted pancreatic islets. Nature Protocols 1, 429-435 (2006).
39. Lacy, P. E., Hegre, O. D., Gerasimidi-Vazeou, A., Gentile, F. T. & Dionne, K. E. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 254, 1782-1784 (1991).
40. Dufrane, D., Goebbels, R. M. & Gianello, P. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression. Transplantation 90, 1054-1062 (2010).
41. Scharp, D. W. et al. Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes 43, 1167-1170 (1994).
42. Waerzeggers, Y. et al. Multimodal imaging of neural progenitor cell fate in rodents. Mol. Imaging 7, 77-91 (2008).
43. Tarantal, A. F., Lee, C. C. & Itkin-Ansari, P. Real-time bioluminescence imaging of macroencapsulated fibroblasts reveals allograft protection in rhesus monkeys (Macaca mulatta). Transplantation 88, 38-41 (2009).
44. Sortwell, C. E., Camargo, M. D., Pitzer, M. R., Gyawali, S. & Collier, T. J. Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval. Exp. Neurol. 169, 23-29 (2001).
45. Kulseng, B., Thu, B., Espevik, T. & Skjak-Braek, G. Alginate polylysine microcapsules as immune barrier: Permeability of cytokines and immunoglobulins over the capsule membrane. Cell Transplant. 6, 387-394 (1997).
46. Keymeulen, B. et al. Correlation between - cell mass and glycemic control in type 1 diabetic recipients of islet cell graft. Proc. Natl Acad. Sci. USA 103, 17444-17449 (2006).
47. Murua, A., Orive, G., Hernandez, R. M. & Pedraz, J. L. Xenogeneic transplantation of erythropoietin-secreting cells immobilized in microcapsules using transient immunosuppression. J. Control. Release 137, 174-178 (2009).
48. Zhao, J. M. et al. Size-induced enhancement of chemical exchange saturation transfer (CEST) contrast in liposomes. J. Am. Chem. Soc. 130, 5178-5184 (2008).
49. Kim, M., Gillen, J., Landman, B. A., Zhou, J. & van Zijl, P. C. Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn. Reson. Med. 61, 1441-1450 (2009).
50. Liu, G., Gilad, A. A., Bulte, J. W., van Zijl, P. C. & McMahon, M. T. High-throughput screening of chemical exchange saturation transfer MR contrast agents. Contrast Media Mol. Imaging 5, 162-170 (2010).